Acute Kidney Failure Clinical Trial
Official title:
Protocol to Assess the Severity of Acute Kidney Injury
The principal objective is to safely determine if we can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and urine for relevant biomarkers. Our goal is to validate if any of these biomarkers can predict the course of AKI (recovery v. RRT v. death)
AKI is a very common disease in the intensive care unit. However, despite advances in supportive care, patients with AKI carry a high mortality rate (50% to 70%). The established AKI affects nearly 5 percent of hospitalized persons and as many as 15 percent of critically ill patients. Currently, there are no FDA approved therapeutic agents for the treatment of AKI. Retrospective studies suggest that the early initiation of renal replacement therapy (RRT) improves outcome. Many clinicians tend to take a "wait and see" approach because they do not want to dialyze a patient who is destined to recover renal function without the need for RRT. Therefore, it is vitally important to know early in the course which patients with AKI are likely to progress to RRT. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00760591 -
Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study)
|
N/A | |
Completed |
NCT00890214 -
Prostacyclin's Effect on Platelet Responsiveness
|
Phase 4 | |
Active, not recruiting |
NCT03675906 -
The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
|
||
Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
Recruiting |
NCT00424320 -
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
|
Phase 3 | |
Completed |
NCT00472563 -
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
|
Phase 2/Phase 3 | |
Withdrawn |
NCT03846258 -
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
|
Phase 4 | |
Completed |
NCT06358365 -
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
|
N/A | |
Completed |
NCT00252200 -
BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.
|
Phase 1/Phase 2 | |
Completed |
NCT04190979 -
Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA)
|
N/A | |
Completed |
NCT04917497 -
Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
|
||
Recruiting |
NCT05309291 -
Theranova Randomized, Controlled, Trial (RCT) in China
|
N/A | |
Completed |
NCT02486614 -
Effect of Citrate on the Coagulation System in Patients Receiving CRRT
|
||
Active, not recruiting |
NCT02470507 -
Immune Function in Acute Kidney Injury
|
||
Active, not recruiting |
NCT05384899 -
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
|
||
Completed |
NCT06190522 -
Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
|
||
Recruiting |
NCT04221932 -
Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"
|
||
Active, not recruiting |
NCT01122225 -
Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury
|
N/A | |
Completed |
NCT00529139 -
Hannover Dialysis Outcome Study
|
Phase 4 |